SlideShare ist ein Scribd-Unternehmen logo
1 von 24
- a neurological
syndrome.
EPIDEMILOGY








In India there is a low prevalence of
Parkinson’s disease. We find it in Parsi
community of Mumbai.
Even though we find early onset of PD and
may even be seen due to mutations.
In ancient India Mucuna pruriens was in used
in the treatment of PD.
But worldwide PD is found in 6 million people.
Neurological disorders reduce the quality of
life.
ETIOLOGY:They are of following types:1.primary75%
2.secondary.25%
1.Primary:
a) They may due to genetic causes. The
mutation in alpha-synuclein, parkin,
UCH1, DJ1, PINK1, LRKK cause PD
cause oxidative stress on mitochondria.
This in turn leads to nigrostriatal death.
b) Some environmental factors.

Secondary causes:1.vascular diseases:-
2.Infectious and post infectious.
Eg:- lyme disease is caused by 3
types of bacteria belonging to
genus borrelia.
Neurosyphilis and AIDS.
 Some toxins such as Mn, cyanide,
methanol, carbon monoxide, pesticides.
 And some medications such as
methyldopa, CCB, lithium and dopamine
depleting agents such as reserpine.
 Rarely it is also due hyoparathyroidsm
due to basal ganglia calcification,
repeated trauma , etc.

PATHOPHYSIOLOGY:Basal ganglia consists of:1.corpus sriatum(caudate nucleus
and putamen).
2.Globus pallidus.
3.Substantia nigra.
*They mediate the extrapyramidal motor
activity.

Basal ganglia
Extrapyramidal surface of brain:
The cerebral
cortex and the
substantia nigra
both project
towards corpus
straitum.
The corpus
striatum(caudat
e nucleus and
putmen)
projects into
globus pallidus
to thalamus and
they regulates
involuntary
movement.
 The

nigro striatal neurons make motor
connections to corpus striatum by 2
types of neurons which contain D1
(excitatory) and D2(inhibitory)
receptors.
 The D1 (excitatory) are glutaminergic
and D2 (inhibitory) are
GABAminergic.
 D1=excitatory

receptors=
acetylcholine as
transmitter=direct.
 D2=inhibitory
receptors=dopamine as
transmitter=indirect.
WHAT HAPPENS IN
PARKINSONISM?
Inhibitory component dopamine is
deficient and its concentration on basal
ganglia is low.
 There is a pathological lesion in basal
ganglia and corpus striatum.
 This occurs due to dopaminergic neuron
degeneration.
 The dopamine is deficient so D2
receptors are less stimulated.

Dopamine
deficiency
PICTURE SHOWING
SUBSTANTIA NIGRA
DEGENERATION.
As the dopaminergic
neurons have their
cell bodies in
substantial nigra. And
as the corpus
striatum receives
dopamine from
substantia nigra
degeneration of these
neurons causes
decrease in the
functional amount of
dopamine.
So eventually
Parkinsonism is due
to imbalance
between
acetylcholine and
dopamine.
Normal
levels of
dopamine
and
acetylcholi
ne
balanced.
SIGNS AND SYMPTOMS:
 Tremor

when sitting and in rest and
may be present only to one side.
 Stiff muscles and aching muscles of
leg, neck, face and other muscles of
body.
 Slow limited movement i;e
bradykinesia.
 Insomnia and nightmares are seen at
very early stage before tremor.
Person
showing
Parkinson's
disease
symptoms.
Weakness of face and throat muscles
making it harder to talk or to swallow.
 Difficulty with walking called gait
instability and postural instability.

COMPLICATIONS OF
PARKINSON’S :
 Depression

and anxiety.
 Sexual dysfunction
 Sleep disorders.
 Urinary incontience.
Parkinsonism

Weitere ähnliche Inhalte

Was ist angesagt?

Parkinson diseases
Parkinson diseasesParkinson diseases
Parkinson diseases
N K
 
Antiparkinsoniandrugs drdhritiupdated2011drdhriti-111228115703-phpapp02
Antiparkinsoniandrugs drdhritiupdated2011drdhriti-111228115703-phpapp02Antiparkinsoniandrugs drdhritiupdated2011drdhriti-111228115703-phpapp02
Antiparkinsoniandrugs drdhritiupdated2011drdhriti-111228115703-phpapp02
Dipesh Kakadiya
 
Parkinson's disease
Parkinson's disease Parkinson's disease
Parkinson's disease
Azmath Sohail
 
Parkinsons disease
Parkinsons diseaseParkinsons disease
Parkinsons disease
mmurralii
 

Was ist angesagt? (20)

Parkinsons Disease
Parkinsons DiseaseParkinsons Disease
Parkinsons Disease
 
Pathophysiology of Parkinsonism
Pathophysiology of ParkinsonismPathophysiology of Parkinsonism
Pathophysiology of Parkinsonism
 
Antiparkinsons
AntiparkinsonsAntiparkinsons
Antiparkinsons
 
Parkinson diseases
Parkinson diseasesParkinson diseases
Parkinson diseases
 
Parkinsonism final
Parkinsonism final Parkinsonism final
Parkinsonism final
 
Antiparkinsoniandrugs drdhritiupdated2011drdhriti-111228115703-phpapp02
Antiparkinsoniandrugs drdhritiupdated2011drdhriti-111228115703-phpapp02Antiparkinsoniandrugs drdhritiupdated2011drdhriti-111228115703-phpapp02
Antiparkinsoniandrugs drdhritiupdated2011drdhriti-111228115703-phpapp02
 
Parkinson by amir
Parkinson by amirParkinson by amir
Parkinson by amir
 
Parkinsonism
ParkinsonismParkinsonism
Parkinsonism
 
Parkinson's disease pharmacology
Parkinson's disease pharmacologyParkinson's disease pharmacology
Parkinson's disease pharmacology
 
Parkinson's disease
Parkinson's disease Parkinson's disease
Parkinson's disease
 
Anti-Parkinson Drugs
Anti-Parkinson DrugsAnti-Parkinson Drugs
Anti-Parkinson Drugs
 
Parkinsonism - management
Parkinsonism - managementParkinsonism - management
Parkinsonism - management
 
Parkinson’s disease
Parkinson’s diseaseParkinson’s disease
Parkinson’s disease
 
Pharmacotherapies for parkinsons disease
Pharmacotherapies for parkinsons diseasePharmacotherapies for parkinsons disease
Pharmacotherapies for parkinsons disease
 
Parkinsons disease
Parkinsons diseaseParkinsons disease
Parkinsons disease
 
Anti parkinsonism drugs by dr.mahi yeruva
Anti parkinsonism drugs by dr.mahi yeruvaAnti parkinsonism drugs by dr.mahi yeruva
Anti parkinsonism drugs by dr.mahi yeruva
 
Parkinsonism
ParkinsonismParkinsonism
Parkinsonism
 
Pharmacotherapy of parkinsons disease
Pharmacotherapy of parkinsons diseasePharmacotherapy of parkinsons disease
Pharmacotherapy of parkinsons disease
 
Understanding the Parkinson's disease
Understanding the Parkinson's diseaseUnderstanding the Parkinson's disease
Understanding the Parkinson's disease
 
Parkinson Disease
Parkinson DiseaseParkinson Disease
Parkinson Disease
 

Andere mochten auch

Journal club 20_sept
Journal club 20_septJournal club 20_sept
Journal club 20_sept
MQ_Library
 

Andere mochten auch (20)

Spect in parkinsonism
Spect in parkinsonismSpect in parkinsonism
Spect in parkinsonism
 
Fabi Camo
Fabi CamoFabi Camo
Fabi Camo
 
Motor tracts
Motor tractsMotor tracts
Motor tracts
 
Frontal lobe epilepsy
Frontal lobe epilepsyFrontal lobe epilepsy
Frontal lobe epilepsy
 
Ebs schwannomatosis
Ebs schwannomatosisEbs schwannomatosis
Ebs schwannomatosis
 
Jc eurotherm3235 ppt
Jc eurotherm3235 pptJc eurotherm3235 ppt
Jc eurotherm3235 ppt
 
Wiedmann ebs
Wiedmann ebsWiedmann ebs
Wiedmann ebs
 
Tfv
TfvTfv
Tfv
 
Ebs wiedmann 18.2.16
Ebs wiedmann 18.2.16Ebs wiedmann 18.2.16
Ebs wiedmann 18.2.16
 
IDH mutations in glioma
IDH mutations in gliomaIDH mutations in glioma
IDH mutations in glioma
 
Macquarie Neurosrgery Evidence Based Surgery
Macquarie Neurosrgery Evidence Based SurgeryMacquarie Neurosrgery Evidence Based Surgery
Macquarie Neurosrgery Evidence Based Surgery
 
Ebs hfs + an
Ebs hfs + anEbs hfs + an
Ebs hfs + an
 
Journal club 20_sept
Journal club 20_septJournal club 20_sept
Journal club 20_sept
 
Anticoagulation in neurosurgery heparin warfarin_ppt
Anticoagulation in neurosurgery heparin warfarin_pptAnticoagulation in neurosurgery heparin warfarin_ppt
Anticoagulation in neurosurgery heparin warfarin_ppt
 
Epileptogenesis - Mechanisms and Clinical Implications
Epileptogenesis - Mechanisms and Clinical ImplicationsEpileptogenesis - Mechanisms and Clinical Implications
Epileptogenesis - Mechanisms and Clinical Implications
 
GRADE 實證醫學 證據評比系統
GRADE 實證醫學 證據評比系統GRADE 實證醫學 證據評比系統
GRADE 實證醫學 證據評比系統
 
Image guidance in neurosurgery
Image guidance in neurosurgeryImage guidance in neurosurgery
Image guidance in neurosurgery
 
Mmd + aneurysms ebs
Mmd + aneurysms ebsMmd + aneurysms ebs
Mmd + aneurysms ebs
 
Trial of Decompressive Craniectomy for Traumatic Intracranial Hypertension
Trial of Decompressive Craniectomy for Traumatic Intracranial HypertensionTrial of Decompressive Craniectomy for Traumatic Intracranial Hypertension
Trial of Decompressive Craniectomy for Traumatic Intracranial Hypertension
 
Reversible cerebral vasoconstriction syndrome
Reversible cerebral vasoconstriction syndromeReversible cerebral vasoconstriction syndrome
Reversible cerebral vasoconstriction syndrome
 

Ähnlich wie Parkinsonism

Parkinsons disease V Pharm.D
Parkinsons disease V Pharm.DParkinsons disease V Pharm.D
Parkinsons disease V Pharm.D
Dr.Sohel Memon
 
Parkinsons disease presentation v2
Parkinsons disease presentation v2Parkinsons disease presentation v2
Parkinsons disease presentation v2
sammyt1996
 

Ähnlich wie Parkinsonism (20)

Parkinsonism & Azheimers
Parkinsonism & AzheimersParkinsonism & Azheimers
Parkinsonism & Azheimers
 
Parkinson's Disease [Advanced Pharmacology]
Parkinson's Disease [Advanced Pharmacology]Parkinson's Disease [Advanced Pharmacology]
Parkinson's Disease [Advanced Pharmacology]
 
Pharmacotherapy of Neurodegenrative diseases
Pharmacotherapy of Neurodegenrative diseases Pharmacotherapy of Neurodegenrative diseases
Pharmacotherapy of Neurodegenrative diseases
 
Prakash park
Prakash parkPrakash park
Prakash park
 
Pathophysiology of Parkinsonism and its management for Pharm.D (Pharmacothera...
Pathophysiology of Parkinsonism and its management for Pharm.D (Pharmacothera...Pathophysiology of Parkinsonism and its management for Pharm.D (Pharmacothera...
Pathophysiology of Parkinsonism and its management for Pharm.D (Pharmacothera...
 
PARKINSON’S DISEASE
PARKINSON’S DISEASE PARKINSON’S DISEASE
PARKINSON’S DISEASE
 
Parkinsonism
ParkinsonismParkinsonism
Parkinsonism
 
Parkinsons disease V Pharm.D
Parkinsons disease V Pharm.DParkinsons disease V Pharm.D
Parkinsons disease V Pharm.D
 
Week 1 Parkinson's disease (1) (1).pptx
Week 1 Parkinson's disease (1) (1).pptxWeek 1 Parkinson's disease (1) (1).pptx
Week 1 Parkinson's disease (1) (1).pptx
 
Antiparkinson drugs
Antiparkinson drugsAntiparkinson drugs
Antiparkinson drugs
 
Parkinsons disease presentation v2
Parkinsons disease presentation v2Parkinsons disease presentation v2
Parkinsons disease presentation v2
 
Parkinsons disease presentation v2
Parkinsons disease presentation v2Parkinsons disease presentation v2
Parkinsons disease presentation v2
 
Parkinson's Disease
Parkinson's DiseaseParkinson's Disease
Parkinson's Disease
 
PARKINSON’S DISEASE.pptx
PARKINSON’S DISEASE.pptxPARKINSON’S DISEASE.pptx
PARKINSON’S DISEASE.pptx
 
Parkinson s disease
Parkinson s diseaseParkinson s disease
Parkinson s disease
 
Parkinsons Disease-Decrease in neurotransmitter secretions.
Parkinsons Disease-Decrease in neurotransmitter secretions.Parkinsons Disease-Decrease in neurotransmitter secretions.
Parkinsons Disease-Decrease in neurotransmitter secretions.
 
Parkinson disease
Parkinson diseaseParkinson disease
Parkinson disease
 
Parkinson's disease
 Parkinson's disease Parkinson's disease
Parkinson's disease
 
NEURODEGENERATIVE DISEASES
NEURODEGENERATIVE DISEASESNEURODEGENERATIVE DISEASES
NEURODEGENERATIVE DISEASES
 
Aposan-Scientific information.pptx
Aposan-Scientific information.pptxAposan-Scientific information.pptx
Aposan-Scientific information.pptx
 

Kürzlich hochgeladen

Spellings Wk 3 English CAPS CARES Please Practise
Spellings Wk 3 English CAPS CARES Please PractiseSpellings Wk 3 English CAPS CARES Please Practise
Spellings Wk 3 English CAPS CARES Please Practise
AnaAcapella
 
The basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxThe basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptx
heathfieldcps1
 

Kürzlich hochgeladen (20)

ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptx
 
This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.
 
Understanding Accommodations and Modifications
Understanding  Accommodations and ModificationsUnderstanding  Accommodations and Modifications
Understanding Accommodations and Modifications
 
How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17
 
General Principles of Intellectual Property: Concepts of Intellectual Proper...
General Principles of Intellectual Property: Concepts of Intellectual  Proper...General Principles of Intellectual Property: Concepts of Intellectual  Proper...
General Principles of Intellectual Property: Concepts of Intellectual Proper...
 
SOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning PresentationSOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning Presentation
 
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptxSKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
 
Kodo Millet PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
Kodo Millet  PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...Kodo Millet  PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
Kodo Millet PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The Basics
 
Spellings Wk 3 English CAPS CARES Please Practise
Spellings Wk 3 English CAPS CARES Please PractiseSpellings Wk 3 English CAPS CARES Please Practise
Spellings Wk 3 English CAPS CARES Please Practise
 
On National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsOn National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan Fellows
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
The basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxThe basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptx
 
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdfUGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
 
Dyslexia AI Workshop for Slideshare.pptx
Dyslexia AI Workshop for Slideshare.pptxDyslexia AI Workshop for Slideshare.pptx
Dyslexia AI Workshop for Slideshare.pptx
 
Making communications land - Are they received and understood as intended? we...
Making communications land - Are they received and understood as intended? we...Making communications land - Are they received and understood as intended? we...
Making communications land - Are they received and understood as intended? we...
 
Food safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdfFood safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdf
 

Parkinsonism